Healthcare provider profile · identity verified

Daljeet Singh, MD

Family Practice · ALISO VIEJO, CA · NPI 1063493328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	625	216
Losartan Potassium	Losartan Potassium	448	142
Amlodipine Besylate	Amlodipine Besylate	380	122
Levothyroxine Sodium	Levothyroxine Sodium	261	85
Rosuvastatin Calcium	Rosuvastatin Calcium	256	86
Lisinopril	Lisinopril	248	81
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	174	31
Metformin Hcl Er	Metformin Hcl	137	51
Omeprazole	Omeprazole	131	62
Metformin Hcl	Metformin Hcl	128	39
Pantoprazole Sodium	Pantoprazole Sodium	123	47
Simvastatin	Simvastatin	121	38
Hydrochlorothiazide	Hydrochlorothiazide	115	39
Prednisone	Prednisone	109	88
Glipizide	Glipizide	106	33
Metoprolol Tartrate	Metoprolol Tartrate	104	34
Albuterol Sulfate Hfa	Albuterol Sulfate	96	60
Atenolol	Atenolol	92	28
Paxlovid	Nirmatrelvir/Ritonavir	88	88
Trazodone Hcl	Trazodone Hcl	85	41
Meloxicam	Meloxicam	84	45
Cephalexin	Cephalexin	81	73
Gabapentin	Gabapentin	80	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	12
Tamsulosin Hcl	Tamsulosin Hcl	76	27
Terazosin Hcl	Terazosin Hcl	75	21
Hydralazine Hcl	Hydralazine Hcl	70	21
Temazepam	Temazepam	69	suppressed
Alendronate Sodium	Alendronate Sodium	67	22
Finasteride	Finasteride	65	22
Furosemide	Furosemide	63	21
Doxycycline Monohydrate	Doxycycline Monohydrate	60	47
Humulin N Kwikpen	Insulin Nph Human Isophane	59	17
Allopurinol	Allopurinol	58	19
Alprazolam	Alprazolam	58	11
Azelastine Hcl	Azelastine Hcl	58	18
Ezetimibe	Ezetimibe	58	20
Pradaxa	Dabigatran Etexilate Mesylate	54	18
Jardiance	Empagliflozin	51	19
Triamcinolone Acetonide	Triamcinolone Acetonide	51	36
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	17
Potassium Chloride	Potassium Chloride	49	14
Pravastatin Sodium	Pravastatin Sodium	49	21
Fluoxetine Hcl	Fluoxetine Hcl	48	16
Ozempic	Semaglutide	48	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	46	20
Sertraline Hcl	Sertraline Hcl	46	19
Pregabalin	Pregabalin	39	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	39	12
Azithromycin	Azithromycin	38	35
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Spironolactone	Spironolactone	37	12
Buspirone Hcl	Buspirone Hcl	36	suppressed
Lorazepam	Lorazepam	36	suppressed
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	11
Clopidogrel	Clopidogrel Bisulfate	35	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	34	34
Bupropion Xl	Bupropion Hcl	34	15
Carvedilol	Carvedilol	34	15
Hydrocortisone	Hydrocortisone	33	21
Tramadol Hcl	Tramadol Hcl	32	13
Lovastatin	Lovastatin	31	11
Valsartan	Valsartan	31	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	30	30
Fenofibrate	Fenofibrate	29	suppressed
Naproxen	Naproxen	29	suppressed
Acyclovir	Acyclovir	28	suppressed
Eliquis	Apixaban	28	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	28	27
Propranolol Hcl	Propranolol Hcl	28	14
Clonazepam	Clonazepam	27	suppressed
Famotidine	Famotidine	27	14
Glipizide Er	Glipizide	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Breyna	Budesonide/Formoterol Fumarate	24	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Mupirocin	Mupirocin	24	20
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Alvesco	Ciclesonide	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Metoprolol Succinate	Metoprolol Succinate	20	suppressed
Terbinafine Hcl	Terbinafine Hcl	20	13
Clobetasol Propionate	Clobetasol Propionate	19	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Testosterone	Testosterone	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Donepezil Hcl	Donepezil Hcl	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Estradiol	Estradiol	17	12
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	14	suppressed
Erythromycin	Erythromycin Base	14	14
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Fluocinolone Acetonide	Fluocinolone/Shower Cap	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error